PCI Pharma Services has acquired Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and subsidiary of Japan-based ...

VERAXA Biotech AG ( VERAXA) has entered a co-discovery alliance with OmniAb, Inc. for the development of a novel bispecific antibody drug conjugate (bsADC) program targeting solid tumors.

Aptar CSP Technologies, part of AptarGroup Inc., has expanded its service offerings with the launch of a cGMP-compliant ...

Following the acquisition of IFF Pharma Solutions, Roquette has created 2 complementary Business Groups: Health & Pharma ...

Formulation challenges can feel like roadblocks — from API incompatibility and dissolution delays to safety concerns and ...

Matica Biotechnology, a specialized CDMO for cell and gene therapies, has partnered with the National Center for Therapeutics ...

Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common stock, plus one non-tradeable contingent ...

Bristol Myers Squibb plans to close its viral vector production facility in Libertyville, IL according to a BMS spokesperson ...

Merck has initiated construction of a $1 billion, 470,000-square-foot biologics center of excellence in Wilmington, Delaware.

An integrated supply chain partner can reduce risk, enable scalability, and preserve capital in today’s volatile market.

CND has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most recent Series A3 offering.

SK pharmteco has opened its new Current Good Manufacturing Practice (CGMP) plasmid suite at its facility in King of Prussia, ...